The High Court of Kenya ruled that the hospital, headquartered in Nairobi, gravely violated the rights of a woman by performing an unauthorized and irreversible surgery that left her with permanent physical and emotional trauma.

The High Court Judge, Justice Alexander Muteti described the actions of the attending gynecologist as “grossly negligent” after he removed the patient’s cervix without her consent during a routine surgical procedure in 2006.

 As a consequence of the illegal surgery, the patient suffered life-altering injuries, leading to the loss of her employment and earning capacity.

The court ruling also noted that the unwarranted removal of the patient’s s cervix was a direct violation of her fundamental rights. The court also noted that the woman sustained life-altering injuries that led to the loss of her employment.

Notably, the patient and her spouse testified to have experienced a profound loss of amenities and consortium, a term referring to the rights arising from the marriage relationship, which significantly diminished their overall quality of life.

The patient specifically highlighted the loss of her cervix led to her loss of sexual enjoyment and inability to sexually satisfy her husband.

While the court exonerated a second medical practitioner involved in the case, the court firmly held Aga Khan University Hospital accountable for  breaching its duty of care.

It was revealed that the hospital had allowed the negligent gynaecologist to practice despite being aware of his prior disbarment from medical practice in Uganda.

This alarming oversight, coupled with the hospital’s failure to provide essential diagnostic equipment like a flexible cystoscope, delayed the detection of severe complications that later required specialized, costly treatment in South Africa.

The court acknowledged the plaintiffs’ detailed claims, including specific special damages incurred, and ultimately ruled that they are entitled to recover both special and general damages, totaling to Ksh.157 million (approximately USD $1.2 million). The former patient informed the court that the nature of her injuries necessitates sustained and continuous medical treatment, for which the compensation also includes future medical costs.

Aga Khan University Hospital has yet to issue an official response.

The new system, developed by Roche Diagnostics, represents a major breakthrough in laboratory medicine. It replaces the fragmented, manual steps of traditional lab testing with a streamlined, automated workflow, from loading and sorting patient samples to analysis, archiving, and reporting. This means not only shorter turnaround times, but also reduced human error, more consistent results, and 24/7 operation.

“We’re proud to support Aga Khan University Hospital in strengthening diagnostic services across East Africa,” said Taofik Oloruko-Oba, Roche’s Country Manager for Kenya and Head of the East Africa Network.“Reliable test results are the foundation of effective healthcare, and this technology makes that possible at scale.”

For patients, this innovation translates directly into better care. Timely and precise diagnoses are critical for treating life-threatening illnesses like cancer, heart disease, and infectious outbreaks and TLA ensures that doctors have the information they need, when they need it. Whether during a routine check-up or a public health emergency, clinicians can act faster and with greater confidence.

“The full automation of our lab process will significantly improve care delivery and diagnostic accuracy,” said Prof. Shahin Sayed, Chair of the Pathology Department at AKUH. “With fewer manual errors, faster results, and continuous operations, we are building trust with our patients and enabling clinicians to deliver timely, effective treatment.”

The Roche TLA system directly responds to global challenges in laboratory medicine including growing test volumes, limited staffing, and the ever-present risk of delay or error. By connecting multiple analyzers onto a single track and automating repetitive tasks, the system boosts both efficiency and scalability, allowing laboratories to better respond to surges in demand such as those experienced during the COVID-19 pandemic.

Moreover, the system includes Nucleic Acid Testing (NAT), a molecular technology that uses real-time PCR to detect infectious agents like HIV, hepatitis B, and hepatitis C at their earliest stages. Integrating NAT within the automated lab process not only ensures greater patient safety, but also boosts throughout, enabling faster and more reliable screening of blood donors and patients alike.

Although most patients will never see the advanced machinery behind their blood tests, the benefits are deeply felt. Faster lab results can mean earlier cancer detection, quicker treatment for sepsis or cardiac events, and better management of chronic diseases like diabetes. As a result, patients experience fewer delays, fewer repeat tests, and better long-term outcomes.

This installation also marks a broader commitment from Roche to expand access to high-quality diagnostics across the African continent. As part of its 10-Year Diagnostics Strategy for Africa, Roche aims to increase access to in-vitro diagnostics tenfold, particularly in underserved regions. The collaboration with AKUH is a cornerstone of this vision pairing cutting-edge technology with ongoing staff training, preventive maintenance, and a robust supply and logistics framework.

As East Africa continues to invest in modern healthcare infrastructure, innovations like Roche’s Total Lab Automation offer a glimpse into a future where high-quality care is accessible, efficient, and resilient not just in elite urban hospitals, but across the region. This milestone at Aga Khan University Hospital is not just a technological upgrade, it’s a paradigm shift for diagnostics, with implications that could ripple across health systems in Africa and beyond.